Stockreport

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis [Yahoo! Finance]

Reviva Pharmaceuticals Holdings, Inc.  (RVPH) 
PDF -Similar patents have also been granted in key markets around the world including the United States, China, and Japan -Brilaroxazine has a novel mechanism of action f [Read more]